Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.

Jun Suzuki; Masaru Iwai; Zhen Li; Jian-Mei Li; Li-Juan Min; Ayumi Ide; Toyofumi Yoshii; Akira Oshita; Masaki Mogi; Masatsugu Horiuchi

doi:10.1097/01.hjh.0000173521.91104.5f

Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.

Identifier:nobleid.org/w1/20260515/DDF4387B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DDF4387B.svg?ark=w1%2F20260515%2FDDF4387B)](https://nobleid.org/work/w1/20260515/DDF4387B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.

Identifier:nobleid.org/w1/20260515/DDF4387B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DDF4387B.svg?ark=w1%2F20260515%2FDDF4387B)](https://nobleid.org/work/w1/20260515/DDF4387B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work